Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;65(3):473-491.
doi: 10.1016/j.jaad.2010.11.061.

Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up

Ali Alikhan  1 , Lesley M Felsten  1 , Meaghan Daly  2 , Vesna Petronic-Rosic  3
Affiliations
Review

Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up

Ali Alikhan et al. J Am Acad Dermatol. 2011 Sep.

Abstract

Vitiligo is an acquired pigmentary disorder of unknown etiology that is clinically characterized by the development of white macules related to the selective loss of melanocytes. The prevalence of the disease is around 1% in the United States and in Europe, but ranges from less than 0.1% to greater than 8% worldwide. A recorded predominance of women may reflect their greater willingness to express concern about cosmetically relevant issues. Half of all patients develop the disease before 20 years of age. Onset at an advanced age occurs but is unusual, and should raise concerns about associated diseases, such as thyroid dysfunction, rheumatoid arthritis, diabetes mellitus, and alopecia areata. Generalized vitiligo is the most common clinical presentation and often involves the face and acral regions. The course of the disease is unpredictable and the response to treatment varies. Depigmentation may be the source of severe psychological distress, diminished quality of life, and increased risk of psychiatric morbidity. Part I of this two-part series describes the clinical presentation, histopathologic findings, and various hypotheses for the pathogenesis of vitiligo based on past and current research.

PubMed Disclaimer

Similar articles

  • Guidelines for the diagnosis and treatment of vitiligo in Japan.
    Oiso N, Suzuki T, Wataya-Kaneda M, Tanemura A, Tanioka M, Fujimoto T, Fukai K, Kawakami T, Tsukamoto K, Yamaguchi Y, Sano S, Mitsuhashi Y, Nishigori C, Morita A, Nakagawa H, Mizoguchi M, Katayama I. Oiso N, et al. J Dermatol. 2013 May;40(5):344-54. doi: 10.1111/1346-8138.12099. Epub 2013 Feb 27. J Dermatol. 2013. PMID: 23441960
  • Vitiligo: a review of the published work.
    Yaghoobi R, Omidian M, Bagherani N. Yaghoobi R, et al. J Dermatol. 2011 May;38(5):419-31. doi: 10.1111/j.1346-8138.2010.01139.x. J Dermatol. 2011. PMID: 21667529 Review.
  • Vitiligo: A Review.
    Bergqvist C, Ezzedine K. Bergqvist C, et al. Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10. Dermatology. 2020. PMID: 32155629 Review.
  • Vitiligo: Pathogenesis, clinical variants and treatment approaches.
    Iannella G, Greco A, Didona D, Didona B, Granata G, Manno A, Pasquariello B, Magliulo G. Iannella G, et al. Autoimmun Rev. 2016 Apr;15(4):335-43. doi: 10.1016/j.autrev.2015.12.006. Epub 2015 Dec 23. Autoimmun Rev. 2016. PMID: 26724277 Review.
  • Colocalization of vitiligo and alopecia areata presenting as poliosis.
    Walker A, Mesinkovska NA, Boncher J, Tamburro J, Bergfeld WF. Walker A, et al. J Cutan Pathol. 2015 Feb;42(2):150-4. doi: 10.1111/cup.12437. Epub 2014 Dec 23. J Cutan Pathol. 2015. PMID: 25388912
See all similar articles

Cited by

See all "Cited by" articles